# Arcus Ventures: portfolio, investments and team > Arcus Ventures is a vc firm based in United States. 14 investments on record, latest Aug 2019. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/arcus-ventures (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Arcus Ventures Last cheque observed Aug 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet New fund $36M, Apr 2014 VC firm Series B Series A Series C Advanced Materials Therapeutics Cheques on record **0%** of best year **0** **cheques in 12 months**, 14 on record Since the last cheque **2638** days **00** hrs **00** min **00** sec Median round **$25M** Rounds led **0 of 14** Mostly in **United States, 100%** Pitch Arcus Ventures ## Arcus Ventures highlights - 01 14 rounds on record - 02 Mostly Series B and Series A: 64% of its rounds ## What they do - **Type:** VC firm (from a list, unverified) - **Cheque size:** Not stated - **Sectors:** Advanced Materials Therapeutics - **Based in:** United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **14 appearances** - **2019** 1 round - **Aug** **[Cleave Therapeutics](https://millionrounds.com/company/cleave-therapeutics)** Series C · US · Businesswire **$12M** With 8 others - **2016** 1 round - **Aug** **[Cleave Bioscience](https://millionrounds.com/company/cleave-bioscience)** Series B · US · FinSMEs **$37M** With 2 others - **2015** 2 rounds - **Sept** **[Exosome Diagnostics](https://millionrounds.com/company/exosome-diagnostics)** Series B · US **$18M** With 4 others - **Jun** **[XTuit Pharmaceuticals](https://millionrounds.com/company/xtuit-pharmaceuticals)** Series A · US **$22M** With 4 others - **2014** 3 rounds - **Sept** **[TRACON Pharmaceuticals](https://millionrounds.com/company/tracon-pharmaceuticals)** Series B · US **$27M** With 5 others - **Jul** **[Epic Sciences](https://millionrounds.com/company/epic-sciences)** Series C · US **$30M** With 4 others - **Mar** **[Exosome Diagnostics](https://millionrounds.com/company/exosome-diagnostics)** Series B · US **$27M** With 4 others - **2013** 1 round - **Mar** **[T2 Biosystems](https://millionrounds.com/company/t2-biosystems)** Series E · US · pevc.dowjones.com **$40M** With 9 others - **2012** 1 round - **Mar** **[Molecular Imaging](https://millionrounds.com/company/molecular-imaging)** Series A · US · molecularimaging.com **$9.9M** With 3 others - **2011** 3 rounds - **Aug** **[T2 Biosystems](https://millionrounds.com/company/t2-biosystems)** Series D · US · masshightech.com **$23M** With 9 others - **May** **[Molecular Imaging](https://millionrounds.com/company/molecular-imaging)** Series A · US · finsmes.com **$7.0M** With 1 other - **Apr** **[TRACON Pharmaceuticals](https://millionrounds.com/company/tracon-pharmaceuticals)** Series A · US · traconpharma.com **$14M** With 1 other - **2010** 2 rounds - **Nov** **[Vascular Pathways](https://millionrounds.com/company/vascular-pathways)** Series B · US · finsmes.com **$14M** With 3 others - **May** **[T2 Biosystems](https://millionrounds.com/company/t2-biosystems)** Series C · US · onbiovc.com **$15M** With 8 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **2 named** JB **James B. Dougherty** Managing Member of the General Partner i Filing they signed SL **Steven L. Soignet** Managing Member of the General Partner i Filing they signed We also hold **5** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. New fund on file **$36M** raised in Apr 2014 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Series B Series A Series C Median round joined **$25M** the round, not its cheque Led 0 of 14 rounds **0%** - **Sole investor:** Never alone - **Last cheque:** Aug 2019 Rounds by stage said on their site - Series B *5* - Series A *4* - Series C *3* - Series D *1* - Series E *1* Cheques by year Led Joined 2010 2019 Often in the room with - [Polaris Partners](https://millionrounds.com/fund/polaris-partners) 4 - [Camros Capital](https://millionrounds.com/fund/camros-capital) 3 - [Flagship Pioneering, LLC](https://millionrounds.com/fund/flagship-pioneering-llc) 3 - [Flybridge](https://millionrounds.com/fund/flybridge) 3 - [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 3 - [Partners Healthcare Group](https://millionrounds.com/fund/partners-healthcare-group) 3 **Pitching Arcus Ventures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Arcus Ventures. A count of rooms they were both in, not a relationship either has claimed. [**Polaris Partners** VC firm **4** rounds together](https://millionrounds.com/fund/polaris-partners)[**Camros Capital** VC firm **3** rounds together](https://millionrounds.com/fund/camros-capital)[**Flagship Pioneering, LLC** VC firm **3** rounds together](https://millionrounds.com/fund/flagship-pioneering-llc)[**Flybridge** VC firm **3** rounds together](https://millionrounds.com/fund/flybridge)[**New Enterprise Associates** VC firm **3** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Partners Healthcare Group** VC firm **3** rounds together](https://millionrounds.com/fund/partners-healthcare-group)[**Physic Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/physic-ventures)[**WS Investments** Investment firm **3** rounds together](https://millionrounds.com/fund/ws-investments)[**Aisling Capital** Private equity **2** rounds together](https://millionrounds.com/fund/aisling-capital)[**Baird Capital** Wealth manager **2** rounds together](https://millionrounds.com/fund/baird-capital)[**Forbion Capital Partners** Private equity **2** rounds together](https://millionrounds.com/fund/forbion-capital-partners)[**NGN Capital** VC firm **2** rounds together](https://millionrounds.com/fund/ngn-capital) ## Recently backed The latest companies Arcus Ventures put money into. [**Cleave Therapeutics** $12M · Aug 2019](https://millionrounds.com/company/cleave-therapeutics) ## Quick answers about Arcus Ventures ### What does Arcus Ventures invest in? Arcus Ventures invests most often at Series B and Series A (64% of the rounds on record), in sectors such as Advanced Materials and Therapeutics. ### How active is Arcus Ventures? 14 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2019. ### What has Arcus Ventures invested in recently? Its most recent investments on record: Cleave Therapeutics (Series C, Aug 2019) and Cleave Bioscience (Series B, Aug 2016). ### How big are Arcus Ventures's cheques? The median round it joins is $25M. ### Does Arcus Ventures lead rounds? Rarely, if at all: none of its 14 investments on record names it as the lead. ### Where does Arcus Ventures invest? Most of the companies it backs are in the United States (100%). ### Is Arcus Ventures investing now? No investments in the last 12 months; the latest was in Aug 2019. ### Who does Arcus Ventures invest alongside? Most often Polaris Partners (4 rounds together), Camros Capital (3 rounds together) and Flagship Pioneering, LLC (3 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=arcus-ventures) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=arcus-ventures)